Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Timothy Kubal"'
Autor:
Diana, Krause, Karen, Sharrah, Anne, Gross, Danielle, Bowers, Daniel, Mulkerin, Nancy, Brandt, Kate, Kennedy, Annie, Austin, Aaron, Begue, Rose, Bell, Cheryl, Raczyk, Todd, Pickard, Timothy, Kubal, Dave, Johnson, Kellyann, Jeffries, Vanna, Dest, Rory, Randall, Jessica, Sugalski, Gabrielle, Zecha
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 13:507-513
Introduction: The utilization of advanced practice providers (APPs) in oncology has been growing over the last decade; however, there is no standard method for assessing an APP’s contributions to oncology care. Methods: The NCCN Best Practices Comm
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:1-4
As difficult as it may be to comprehend, quality affordable healthcare, particularly cancer care, is not accessible to every individual in every region of the United States. Without timely use of the full range of cancer care services, the best healt
Autor:
Jessica M, Sugalski, Theresa, Franco, Lawrence N, Shulman, Elizabeth, Souza, Ephraim, Hochberg, Anne, Chiang, Scott, Lawrence, Diana, Krause, Timothy, Kubal
Publikováno v:
Journal of the National Comprehensive Cancer Network. :1-4
The NCCN Best Practices Committee, which is composed of senior physician, nursing, and administrative leaders from NCCN Member Institutions, evaluated the status of cancer center operations after 1 year of operating during the COVID-19 pandemic. Two
Publikováno v:
Annals of allergy, asthmaimmunology : official publication of the American College of Allergy, Asthma,Immunology.
Autor:
Matthew A. Lunning, Rafael Fonseca, Dori Klemanski, Kim Slusser, Hope E. Uronis, James J. Bachman, Lawrence N. Shulman, Asmita Mishra, Catherine Liu, Pelin Cinar, Alison G. Freifeld, Timothy Kubal
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:504-509
The novel coronavirus, SARS-CoV-2, was first detected as a respiratory illness in December 2019 in Wuhan City, China. Since then, coronavirus disease 2019 (COVID-19) has impacted every aspect of our lives worldwide. In a time when terms such as socia
Autor:
Katherine Tobon, Diedra K. Frantz, Chetasi Talati, Amber Lubas, Timothy Kubal, Christopher Salamanca
Publikováno v:
Future Oncology. 16:281-291
Historically, patients with acute myeloid leukemia received intensive chemotherapy requiring hospitalization, which can diminish quality of life and increase healthcare costs. The introduction of new therapies facilitated a shift toward outpatient th
Autor:
moderated by Timothy Kubal, Andrew J. Wagner, Thomas K. Varghese, James E. Bachman, Kim Slusser
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:593-595
A panel of experts in healthcare administration and delivery convened virtually during the NCCN 2021 Virtual Annual Conference to discuss the effects of the pandemic on cancer care and what the future may hold. The discussion ranged from the effects
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 28(8)
Introduction The standard of care consolidation therapy for acute myeloid leukemia is high-dose cytarabine or intermediate-dose cytarabine, which are traditionally given inpatient. At Moffitt Cancer Center, we have moved the administration of high-do
Autor:
Diedra K. Frantz, Jessica Sugalski, Gina M. Szymanski, Connie Augustyniak, Jeanine Gordon, Sharol K. Kidd, Timothy Kubal, Robert W. Carlson, F. Marc Stewart, Diana Krause, Rosanna Fiorarancio Fahy, Penny J. Moore, Marisa A. Quinn, MiKaela Olsen, Daniel Mulkerin, Rebecca L. Caires
Publikováno v:
Journal of Oncology Practice. 15:e458-e466
PURPOSE: The National Comprehensive Cancer Network (NCCN) formed an Infusion Efficiency Workgroup to determine best practices for operating efficient and effective infusion centers. METHODS: The Workgroup conducted three surveys that were distributed
Autor:
Neil T, Mason, Jason M, Burkett, Ryan S, Nelson, Julio M, Pow-Sang, Robert A, Gatenby, Timothy, Kubal, John W, Peabody, G Douglas, Letson, Howard L, McLeod, Jingsong, Zhang
Publikováno v:
Am Health Drug Benefits
BACKGROUND: The use of a novel strategy known as adaptive abiraterone therapy based on mathematical modeling of evolutionary dynamics of tumor subpopulations was shown in a clinical trial to extend the time to disease progression in patients with met